1-5 of 5
malignant mesothelioma of pleura
Close
Sort by
Journal Articles

Management of Cancer-Associated Upper Extremity Deep Vein Thrombosis with and without Venous Catheters at a Tertiary Care Center

Said Y. ALKindi, MD ARCPath, Chatree Chai-Adisaksopha, MD, Matthew Cheah, Lori Ann Linkins, MD MSc, FRCPC
Journal: Blood
Blood (2015) 126 (23): 1119.
https://doi.org/10.1182/blood.V126.23.1119.1119
Published: 2015
Journal Articles

Endothelial Cell Protein C Receptor Promotes Apoptosis in Malignant Pleural Mesothelioma Cells

Shiva Keshava, PhD, L. Vijaya Mohan Rao, PhD, Usha R. Pendurthi, PhD
Journal: Blood
Blood (2015) 126 (23): 2241.
https://doi.org/10.1182/blood.V126.23.2241.2241
Published: 2015
Journal Articles

Vaccination with WT1 mRNA-Electroporated Dendritic Cells: Report of Clinical Outcome in 66 Cancer Patients

Zwi N. Berneman, Ann L. Van de Velde, Yannick Willemen, Sébastien Anguille, Kirsten Saevels, Paul Germonpré, Manon T. Huizing, Marc Peeters, Annemie Snoeckx, Paul Parizel, Viggo F Van Tendeloo, Eva Lion, Griet Nijs, Barbara Stein, Katrien Vermeulen, Marie-Berthe Maes, Ronald Malfait, Inge Vrelust, Anke Verlinden, Alain P. Gadisseur, Wilfried A Schroyens, Martin Lammens, Evelien L. Smits
Journal: Blood
Blood (2014) 124 (21): 310.
https://doi.org/10.1182/blood.V124.21.310.310
Published: 2014
Journal Articles

Vantage 088: Vorinostat in Combination with Bortezomib in Patients with Relapsed/Refractory Multiple Myeloma: Results of a Global, Randomized Phase 3 Trial

Meletios Athanasios Dimopoulos, MD, Sundar Jagannath, MD, Sung-Soo Yoon, MD, PhD, David S. Siegel, MD, PhD, Sagar Lonial, MD, Roman Hajek, MD, PhD, Thierry Facon, MD, Laura Rosiñol, MD, Hilary Anne Blacklock, MD, Hartmut Goldschmidt, MD, Vania Hungria, MD, Andrew Spencer, MD, Antonio Palumbo, MD, Donna E. Reece, MD, FRCPC, Thorsten Graef, MD, PhD, Jennifer Houp, Linda Sun, PhD, Joseph E. Eid, MD, Kenneth C. Anderson, MD
Journal: Blood
Blood (2011) 118 (21): 811.
https://doi.org/10.1182/blood.V118.21.811.811
Published: 2011
Journal Articles

Vantage 095: Vorinostat in Combination with Bortezomib in Salvage Multiple Myeloma Patients: Final Study Results of a Global Phase 2b Trial

David S. Siegel, MD, PhD, Meletios Athanasios Dimopoulos, MD, Sung-Soo Yoon, MD, PhD, Jacob P. Laubach, MD, Jonathan L. Kaufman, MD, Hartmut Goldschmidt, MD, Donna E. Reece, MD, FRCPC, Xavier Leleu, MD, PhD, Simon Durrant, MBBS, FRCP, FRCPath, Fritz C. Offner, MD, PhD, Michele Cavo, MD, Arnon Nagler, MD, Sundar Jagannath, MD, Thorsten Graef, MD, PhD, Jennifer Houp, Linda Sun, PhD, Jason Howe, Sandra M. Wear, RN, Kenneth C. Anderson, MD
Journal: Blood
Blood (2011) 118 (21): 480.
https://doi.org/10.1182/blood.V118.21.480.480
Published: 2011